🇺🇸 FDA
Patent

US 7148197

Orally administered small peptides synergize statin activity

granted A61KA61K31/366A61K31/405

Quick answer

US patent 7148197 (Orally administered small peptides synergize statin activity) held by The Regents of the University of California expires Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 12 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 07 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
85
CPC classes
A61K, A61K31/366, A61K31/405, A61K31/44, A61K31/47